Diffuse

: An aggressive cancer of the B-lymphocytes (white blood cells) that normally help the body fight infections. It is the most common subtype of non-Hodgkin lymphoma, accounting for approximately 30–40% of adult cases worldwide. Key Characteristics :

Comprehensive industry reports and epidemiology forecasts provide the following data for 2024: diffuse

: Despite its speed, it is often curable with systemic regimens such as R-CHOP or newer targeted therapies like Pola-R-CHP. Market & Epidemiology Insights (2024–2025) : An aggressive cancer of the B-lymphocytes (white